Company
AGIOS PHARMACEUTICALS, INC.
AGIO · CIK 0001439222
Acquisition (code M) of 500 shares at $25.01 per share.
Reporting Person Gheuens Sarah · Officer Title Chief Medical Officer · Transaction Code M
Traded Oct 22, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001439222-26-000122 · filed 2026-10-23 · View filing →
Sale of 500 shares at $37.52 per share.
Reporting Person Gheuens Sarah · Officer Title Chief Medical Officer · Transaction Code S
Traded Oct 22, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001439222-26-000122 · filed 2026-10-23 · View filing →
Acquisition (code M) of 1,489 shares at $25.01 per share.
Reporting Person Gheuens Sarah · Officer Title Chief Medical Officer · Transaction Code M
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001439222-26-000122 · filed 2026-10-23 · View filing →
Sale of 1,489 shares at $37.53 per share.
Reporting Person Gheuens Sarah · Officer Title Chief Medical Officer · Transaction Code S
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001439222-26-000122 · filed 2026-10-23 · View filing →
STOCK ACT PTR
$1,001 - $15,000
Purchase.
Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock
Traded Aug 20, 2026 · Disclosed Sep 10, 2026FILED +21 DAYS
Source: House Clerk PTR · 20035390 · filed 2026-09-10 · View filing →